• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).克罗地亚国家结直肠癌筛查计划的结果(2007-2011 年)。
World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.
2
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
3
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
4
Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.结直肠癌的早期检测:一项用于验证联合DNA粪便检测的多中心临床前病例队列研究
Clin Lab. 2018 Oct 1;64(10):1719-1730. doi: 10.7754/Clin.Lab.2018.180521.
5
Contribution of the OC Sensor immunoassay in comparison to the Hemoccult II guaiac-test in organized colorectal cancer screening.OC 传感器免疫测定与 Hemoccult II 愈创木脂检测在有组织的结直肠癌筛查中的比较。
Eur J Epidemiol. 2019 Feb;34(2):163-172. doi: 10.1007/s10654-018-0471-z. Epub 2018 Dec 8.
6
Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.采用高敏免疫化学粪便隐血试验筛查家族性结直肠癌:一项初步研究。
Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1062-7. doi: 10.1097/MEG.0b013e3283293797.
7
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].[用于结直肠癌筛查中粪便潜血检测的化学或免疫检测?]
Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3.
8
[CONTRIBUTION OF FAMILY MEDICINE TO COLORECTAL CANCER PREVENTION AND EARLY DETECTION; FORTY-YEAR EXPERIENCE OF FAMILY MEDICINE DEPARTMENT, OSIJEK HEALTH CENTER].[家庭医学对结直肠癌预防和早期检测的贡献;奥西耶克健康中心家庭医学科四十年经验]
Acta Med Croatica. 2015 Nov;69(4):373-80.
9
Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.在一项针对结直肠癌筛查计划中,对粪便隐血试验呈阳性的个体进行免疫化学检测:一项观察性研究。
Lancet Oncol. 2006 Feb;7(2):127-31. doi: 10.1016/S1470-2045(05)70473-3.
10
Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.与结直肠癌筛查相关的医疗保健成本、资源利用和生产力损失。
Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(7):843-852. doi: 10.1080/14737167.2023.2220965. Epub 2023 Jul 18.

引用本文的文献

1
QUALITY OF LIFE OF OSTOMATES - A QUALITATIVE STUDY.造口患者的生活质量——一项定性研究。
Acta Clin Croat. 2024 Apr;63(1):29-35. doi: 10.20471/acc.2024.63.01.4.
2
Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History.在加泰罗尼亚进行的结直肠癌人群筛查中诊断出的无症状炎症性肠病:特征与自然史
Clin Transl Gastroenterol. 2025 Feb 1;16(2):e00740. doi: 10.14309/ctg.0000000000000740.
3
Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease.炎症性肠病早期阶段的最新进展及潜在的多组学方法
J Clin Med. 2023 May 11;12(10):3418. doi: 10.3390/jcm12103418.
4
Endoscopic features and clinical course of patients with asymptomatic cecal ulcers.无症状性盲肠溃疡患者的内镜特征和临床病程。
BMC Gastroenterol. 2022 Jun 24;22(1):309. doi: 10.1186/s12876-022-02383-x.
5
Implementation and results of a gastrointestinal cancer screening program in an Amazon rainforest village: A descriptive study.亚马逊雨林村庄胃肠道癌症筛查项目的实施与结果:一项描述性研究。
Endosc Int Open. 2021 Jun;9(6):E770-E776. doi: 10.1055/a-1386-2095. Epub 2021 May 27.
6
Adenoma Characteristics and the Influence of Alcohol and Cigarette Consumption on the Development of Advanced Colorectal Adenomas.腺瘤特征以及酒精和吸烟消费对进展期结直肠腺瘤发生的影响。
Int J Environ Res Public Health. 2020 Nov 10;17(22):8296. doi: 10.3390/ijerph17228296.
7
Diagnosis and natural history of preclinical and early inflammatory bowel disease.临床前及早期炎症性肠病的诊断与自然史
Ann Gastroenterol. 2020 Sep-Oct;33(5):443-452. doi: 10.20524/aog.2020.0508. Epub 2020 Jun 22.
8
Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey.欧洲国家按筛查类型划分的结直肠癌筛查测试使用情况:欧洲健康访谈调查结果
Cancers (Basel). 2020 May 29;12(6):1409. doi: 10.3390/cancers12061409.
9
The Web-Based Randomized Controlled Intervention as the Enhancer of Cancer Prevention.基于网络的随机对照干预作为癌症预防的增强手段。
Medicina (Kaunas). 2019 Aug 3;55(8):434. doi: 10.3390/medicina55080434.
10
The First Screening Program for Colorectal Cancer in the North of Iran.伊朗北部的首个结直肠癌筛查项目。
J Gastrointest Cancer. 2020 Mar;51(1):165-171. doi: 10.1007/s12029-019-00226-9.

本文引用的文献

1
A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer.基于人群的初级保健中粪便隐血试验用于结直肠癌的临床应用审计。
Colorectal Dis. 2012 Sep;14(9):e539-46. doi: 10.1111/j.1463-1318.2012.03149.x.
2
Isolated colorectal cancer screening or integrated cancer prevention? A provocative suggestion!结直肠癌筛查孤立化或癌症综合防治?一个颇具争议的建议!
Dig Dis. 2012;30(3):316-9. doi: 10.1159/000337005. Epub 2012 Jun 20.
3
Colorectal cancer screening behavior and willingness.结直肠癌筛查行为和意愿。
World J Gastroenterol. 2012 Jun 14;18(22):2885-6. doi: 10.3748/wjg.v18.i22.2885.
4
False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.2000-2010 年加泰罗尼亚(西班牙)结直肠癌筛查的假阳性结果。
J Med Screen. 2012 Jun;19(2):77-82. doi: 10.1258/jms.2012.012013. Epub 2012 May 31.
5
Screening for colorectal cancer: what fits best?结直肠癌筛查:哪种方法最合适?
Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):301-12. doi: 10.1586/egh.12.12.
6
Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.基于人群的免疫化学粪便潜血试验筛查结直肠癌:两种邀请策略的比较。
Cancer Epidemiol. 2012 Oct;36(5):e317-24. doi: 10.1016/j.canep.2012.04.003. Epub 2012 May 5.
7
Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.1988 - 2008年克罗地亚胃癌和结直肠癌的发病率及死亡率趋势
Croat Med J. 2012 Apr;53(2):124-34. doi: 10.3325/cmj.2012.53.124.
8
Early detection of colorectal cancer: barriers to screening in the primary care setting.结直肠癌的早期检测:初级保健环境中的筛查障碍。
Fam Pract. 2011 Dec;28(6):589-91. doi: 10.1093/fampra/cmr110.
9
Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.直接邮寄粪便隐血试验用于结直肠癌筛查:来自意大利中部的一项随机人群研究。
J Med Screen. 2011;18(3):121-7. doi: 10.1258/jms.2011.011009.
10
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.

克罗地亚国家结直肠癌筛查计划的结果(2007-2011 年)。

Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

机构信息

Miroslava Katičić, Department of Gastroenterology, Merkur University Hospital, 10000 Zagreb, Croatia.

出版信息

World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.

DOI:10.3748/wjg.v18.i32.4300
PMID:22969192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3436044/
Abstract

AIM

To study the epidemiologic indicators of uptake and characteristic colonoscopic findings in the Croatian National Colorectal Cancer Screening Program.

METHODS

Colorectal cancer (CRC) was the second leading cause of cancer mortality in men (n = 1063, 49.77/100,000), as well as women (n = 803, 34.89/100,000) in Croatia in 2009. The Croatian National CRC Screening Program was established by the Ministry of Health and Social Welfare, and its implementation started in September, 2007. The coordinators were recruited in each county institute of public health with an obligation to provide fecal occult blood testing (FOBT) to the participants, followed by colonoscopy in all positive cases. The FOBT was performed by hypersensitive guaiac-based Hemognost card test (Biognost, Zagreb). The test and short questionnaire were delivered to the home addresses of all citizens aged 50-74 years consecutively during a 3-year period. Each participant was required to complete the questionnaire and send it together with the stool specimen on three test cards back to the institute for further analysis. About 4% FOBT positive cases are expected in normal risk populations. A descriptive analysis was performed.

RESULTS

A total of 1,056,694 individuals (born between 1933-1945 and 1952-1957) were invited to screening by the end of September 2011. In total, 210,239 (19.9%) persons returned the envelope with a completed questionnaire, and 181,102 of them returned it with a correctly placed stool specimen on FOBT cards. Until now, 12,477 (6.9%), FOBT-positive patients have been found, which is at the upper limit of the expected values in European Guidelines for Quality Assurance in CRC Screening and Diagnosis [European Union (EU) Guidelines]. Colonoscopy was performed in 8541 cases (uptake 66%). Screening has identified CRC in 472 patients (5.5% of colonoscopied, 3.8% of FOBT-positive, and 0.26% of all screened individuals). This is also in the expected range according to EU Guidelines. Polyps were found and removed in 3329 (39% of colonoscopied) patients. The largest number of polyps were found in the left half of the colon: 64% (19%, 37% and 8% in the rectum, sigma, and descendens, respectively). The other 36% were detected in the proximal part (17% in the transverse colon and 19% in ceco-ascending colon). Small polyps in the rectum (5-10 mm in diameter), sigmoid and descending colon were histologically found to be tubular adenomas in 60% of cases, with a low degree of dysplasia, and 40% were classified as hyperplastic. Polyps of this size in the transverse or ceco-ascending colon in almost 20% had a histologically villous component, but still had a low degree of dysplasia. Polyps sized 10-20 mm in diameter were in 43% cases tubulovillous, and among them, 32% had areas with a high degree of dysplasia, especially those polyps in the ceco-ascending or transverse part. The characteristics of the Croatian CRC Screening National Program in the first 3 years were as follows: relatively low percentage of returned FOBT, higher number of FOBT-positive persons but still in the range for population-based programs, and higher number of pathologic findings (polyps and cancers).

CONCLUSION

These results suggest a need for intervention strategies that include organizational changes and educational activities to improve awareness of CRC screening usefulness and increase participation rates.

摘要

目的

研究克罗地亚国家结直肠癌筛查计划中采用率的流行病学指标和特征性结肠镜检查结果。

方法

2009 年,结直肠癌(CRC)是克罗地亚男性(n=1063,49.77/100000)和女性(n=803,34.89/100000)的第二大癌症死亡原因。克罗地亚国家 CRC 筛查计划由卫生部和社会福利部设立,于 2007 年 9 月开始实施。协调员在每个县的公共卫生研究所招聘,有义务向参与者提供粪便潜血试验(FOBT),然后对所有阳性病例进行结肠镜检查。FOBT 通过超敏基于愈创木脂的 Hemognost 卡片试验(Biognost,萨格勒布)进行。该试验和简短问卷在 3 年内连续递送到所有 50-74 岁公民的家庭住址。要求每位参与者填写问卷,并将 3 张粪便标本的卡片寄回研究所进行进一步分析。在正常风险人群中,预计有 4%的 FOBT 阳性病例。进行了描述性分析。

结果

截至 2011 年 9 月底,共有 1056694 人(1933-1945 年和 1952-1957 年出生)受邀参加筛查。共有 210239 人(19.9%)返回了带有完整问卷的信封,其中 181102 人将其与 FOBT 卡上正确放置的粪便标本一起返回。迄今为止,发现了 12477 名(6.9%)FOBT 阳性患者,这处于欧洲 CRC 筛查和诊断质量保证指南[欧盟(EU)指南]的预期值上限。对 8541 例(采用率 66%)患者进行了结肠镜检查。筛查发现 472 例 CRC(结肠镜检查的 5.5%,FOBT 阳性的 3.8%,所有筛查个体的 0.26%)。这也符合欧盟指南的预期范围。在 3329 例(结肠镜检查的 39%)患者中发现并切除了息肉。左半结肠发现的息肉数量最多:64%(直肠、乙状结肠和降结肠分别为 19%、37%和 8%)。其余 36%位于近端(横结肠 17%,升结肠和降结肠 19%)。直肠(直径 5-10 毫米)、乙状结肠和降结肠的小息肉在 60%的病例中组织学上发现为管状腺瘤,低度异型增生,40%被归类为增生性。在几乎 20%的横结肠或升结肠的这些大小的息肉中,组织学上有绒毛成分,但仍有低度异型增生。直径 10-20 毫米的息肉在 43%的病例中为管状绒毛状,其中 32%有高度异型增生区域,尤其是在升结肠或横结肠部分的息肉。克罗地亚 CRC 筛查国家计划前 3 年的特征如下:返回 FOBT 的百分比相对较低,FOBT 阳性人数较多,但仍在基于人群的计划范围内,病理发现(息肉和癌症)较多。

结论

这些结果表明,需要采取干预策略,包括组织变革和教育活动,以提高对 CRC 筛查有用性的认识并提高参与率。